China Shineway Pharmaceutical

China Shineway Pharmaceutical's reported carbon emissions

China Shineway Pharmaceutical, headquartered in CN and operating within the Pharmaceutical Preparation Manufacturing industry, has reported its carbon emissions and climate commitments. For the year 2021, the company's total greenhouse gas (GHG) emissions were approximately 117,794,000 kg CO2e. This total comprised Scope 1 emissions of about 76,087,000 kg CO2e, Scope 2 emissions of approximately 16,885,000 kg CO2e, and Scope 3 emissions of around 24,822,000 kg CO2e. In the preceding year, 2020, China Shineway Pharmaceutical reported total emissions of approximately 130,989,000 kg CO2e, with Scope 1 at 100,252,000 kg CO2e, Scope 2 at 7,391,000 kg CO2e, and Scope 3 at 23,345,000 kg CO2e. Prior to that, in 2019, the company's total emissions were approximately 145,136,000 kg CO2e, broken down into Scope 1 at 111,082,000 kg CO2e, Scope 2 at 9,492,000 kg CO2e, and Scope 3 at 24,561,000 kg CO2e. For the year 2018, total emissions stood at approximately 145,465,000 kg CO2e, including Scope 1 emissions of about 108,236,000 kg CO2e, Scope 2 emissions of approximately 13,184,000 kg CO2e, and Scope 3 emissions of around 24,045,000 kg CO2e. In 2017, China Shineway Pharmaceutical's total emissions were approximately 153,410,000 kg CO2e. This included Scope 1 emissions of around 117,620,000 kg CO2e, Scope 2 emissions of about 8,186,000 kg CO2e, and Scope 3 emissions of approximately 27,604,000 kg CO2e. The company's emissions data is cascaded from its ultimate parent, China Shineway Pharmaceutical Group Limited. Currently, there are no disclosed reduction targets, including those from the Science Based Targets initiative (SBTi), or commitments to schemes like the Climate Pledge. The company's latest available reports for 2022, 2023, and 2024 do not contain specific absolute emissions data for Scope 1, 2, or 3. Instead, these reports provide various intensity metrics, such as GHG intensity per unit of revenue, per fixed assets, and per employee, indicating a focus on relative emissions performance rather than absolute reduction targets.